Navigation Links
Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
Date:11/21/2008

CLINTON, N.J., Nov. 21 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that it has been named Private Company of the Year by the New Jersey Technology Council (NJTC), a 1,200-member non-profit organization that provides business support, networking opportunities, information and advocacy for technology companies and their leaders. Ikaria earned the award based on criteria including market leadership and unique product/service provision.

"We are delighted that the New Jersey Technology Council has recognized Ikaria for its leadership and innovation in critical care medicine," said Daniel Tasse, President and CEO of Ikaria. "This award is a testament to the hard work and pioneering spirit of our organization to deliver novel treatments for patients with unmet medical needs within the underserved critical care market."

Ikaria was honored at the NJTC Awards Gala on November 20, 2008, an annual black-tie event that attracts over 500 attendees. The NJTC Awards was founded in 1996 to publicly recognize and celebrate some of the most successful companies in the New Jersey technology community.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceuticals and drug-device combinations for hospitalized, critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Australia and Latin America. INOmax recently was approved for marketing in Japan. Ikaria is engaged in new and ongoing clinical development of INOmax, Covox(R) (carbon monoxide) for inhalation and hydrogen sulfide. Recently, Ikaria acquired the North American rights to terlipressin, which currently is under review by the FDA for the treatm
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. American Board of Internal Medicine President Named to Alzheimers Study Group
3. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
4. Pharmaxis Establishes Named Patient Program for Bronchitol
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
7. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
8. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
9. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... TOWN OF HEMPSTEAD, N.Y., Nov. 9 /PRNewswire/ -- ...ice officers and other rescue workers came togethe...ty. Merrick firefighter Brian McCauley was one of ... save his own life. ,, Only in his late 30s, Mc...ndergone surgery and extensive chemotherapy treatm...
(Date:11/9/2009)... PALO ALTO, Calif., Nov. 9 Women,s...t has changed its name to Viveve as it prepares fo... select U.S. markets. ,, "Viveve is a name that...cus on women,s sexual health," said Kerry Pope, Vi...ts for the sole purpose of helping women restore t...
(Date:11/9/2009)... NATICK, Mass., Nov. 9 B...nnounced the launch of its COGNIS® cardiac re...TELIGEN® implantable cardioverter defibrillat... the Japanese Ministry of Health, Labor and Welfar...oval in September. COGNIS and TELIGEN are the res...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 1Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...05, 2007 /PRNewswire/ -- Results from,the primary ...Phase,3 study showed that 77 percent of treatment-...TM) (darunavir) 600 mg tablets with,100 mg ritonav...kground regimen (OBR) of antiretroviral (ARV) agen...at week 48, compared to 68,percent of patients tak...
...INESS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncology, Inc....ta,from an ongoing phase II trial of ZIO-201 (isop...oma patients was presented at the,European Society...,2007 in Lugano, Switzerland. The abstract entitle...Sarcoma," was presented by,Rashmi Chugh, MD, a Pri...
Other Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
(Date:11/9/2009)...Study didn,t answer question of why this is so, ho...ws) -- After a lumpectomy, women with very dense b...the affected breast, a new study shows. , Breas...d risk of developing breast cancer, and experts ha...ssociated with an increased risk of cancer recurre...
(Date:11/9/2009)...,, CAMBRIDGE, Mass., Nov. 9 A...nd capabilities in delivering emergency management...ly awarded contracts to support the work of the Fe...of Regional Operations, the National Commission on...litan Area Transit Authority (WMATA). The value o...
(Date:11/9/2009)...,, WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -...PA), representing more than 75,000 clinically prac...e United States, applauds the U.S. House of Repres...orm bill, H.R. 3962, the Affordable Health Care fo...that this reform bill will ultimately lower the co...
(Date:11/9/2009)... This release is available in French . , ,... came in twos: male and female. In human bodies tr...molecules from which they are composed. Yet these...tinguishable clusters. Because these complex cell ...ientists have long searched for ways to splice cel...
(Date:11/9/2009)... As many as 10 million people around the world su...niversity in Frankfurt and his coauthors discuss c...cial lens in the current issue of Deutsches rzteb...[43]: 695�). , Blindness is usually due t...e than 600,000 cataract operations are performed e...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
... with high infection rates has got support from Bi... a stigma attached to the deadly illness and the l...o and so AIDS testing was frowned upon. Accord...er universal testing. As told to journalists ...
...al of a new technology called nanotechnology, it o... more than an eccentric concept //. The term ‘Nano...y small machines from nanometer size units that ar...rnment organizations and multinational companies a...
...ple and natural remedy for reducing the intensity .../ by just eating more fruits and vegetables. They ...in antioxidants, are capable of accelerating and w...s of antioxidants, like carotene and lycopene in t...
...erta confirms the popular myth that Rodeo cowboys ...n whiplash injuries, Dr. Robert Ferrari, clinical ...y of Alberta, has found that conducted the cultura...th Faculty of Agriculture of the University of Alb...
...nducted this study which was self funded. The swee... or sourness of the sweetener. // The researchers ...ked to rate 13 different sweeteners and sweet subs...und sucralose (brand name Splenda), a sweetener de...
... confirmed coliform bacteria and diatoms in some s...Spring Water//, Ltd. For this reason North Countr...ecalling all of its bottled water products. Colif...nitary Code. Coliform bacteria may indicate the pr...
Other Medicine News:Health News:Nanotechnology Promises Huge Medical Benefits 2Health News:Quick Recovery in Rodeo Athletes 2Health News:Sweet, Sweeter and Sweetest 2
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: